Finnovate Acquisition Corp. (FNVTU) Prices $150M IPO
by Marlena Haddad on 2021-11-03 at 5:32pm

Finnovate Acquisition Corp. announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “FNVTU” Thursday, November 3.

The new SPAC intends to focus its search on fintech companies that are domiciled in Israel, that carry out all or a substantial portion of their activities in Israel, or that have some other significant Israeli connection. Finnovate is managed by Prof. David Gershon (former founder and CEO of SuperDerivatives) who will serve as Chairman and CEO, Ron Golan (former head of investment banking and capital markets at Morgan Stanley for Israel & CEE) will serve as Director and CFO, and Jonathan Ophir (Former Head of Credit Division, at Altshuler Shaham) will serve as CIO. Uri Chaitchik will serve as a senior consultant to the Company. The Company’s independent directors are Mitch Garber (former CEO of Caesars Acquisition Company), Gustavo Schwed (Former Partner at Morgan Stanley Private Equity and Providence Equity Partners) and Nadav Zohar (Chairman of LRC Europe).

Total SPAC deal count for 2021 year-to-date is now 513. This offering is expected to close on Monday, November 8.


EarlyBirdCapital, Inc. is serving as sole book-running manager for the offering. McDermott Will & Emery LLP is serving as Issuer’s Counsel with Graubard Miller serving as Underwriter’s Counsel.  Marcum, LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2024-03-26 at 1:52pm

News and Rumors SpaceNews: Boeing (NYSE:BA) has sued Virgin Galactic (NASDAQ:SPCE) alleging the space tourism venture refused to pay $25 million it owed for design work and violated Boeing’s intellectual property rights. Virgin Galactic combined with Social Capital Hedosophia in 2019. Bloomberg: The most popular options contract for Trump Media (NASDAQ:DJT) predicts it to plunge...

by Nicholas Alan Clayton on 2024-03-26 at 11:51am

APx (NASDAQ:APXI) has entered into a definitive agreement to combine with precision medicine firms OmnigenicsAI and MultiplAI at an enterprise value $340 million. Once combined, these companies will offer DNA tests to consumers linked to predictive insights on their nutritional and genomic health. The combined company is expected to trade on the Nasdaq under the...

by Nicholas Alan Clayton on 2024-03-26 at 7:45am

At the SPAC of Dawn With the pricing of IB Acquisition Corp. (NASDAQ:IBACU), March now officially has two SPAC IPOs in the books but we”ll have to see if three price to match February’s numbers. The move brings 2024’s total count to six SPAC IPOs, which continues to be a slower pace than 2023, which turned...

by Kristi Marvin on 2024-03-25 at 6:37pm

IB Acquisition Corp. (NASDAQ:IBACU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “IBACU”, Tuesday, March 26, 2024. The new SPAC will have a broad search focus and will not be limited to a particular geographic region or industry, but believe there...

by Kristi Marvin on 2024-03-25 at 3:24pm

They say timing is everything and at the end of a week punctuated by two successful traditional IPOs from Astera and Reddit, the sponsor team that announced the CCIV/Lucid deal at the absolute peak of the capital markets insanity that was Q1-2021 dropped their latest new SPAC – Churchill Capital Corp. IX. Is this a...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved